Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a performance status rated between 0 and 3 on the ECOG scale, meaning they are able to carry out at least some daily activities (confirm with trial site)
- People who are expected to live for more than 6 months
- People who are willing to give their consent and have a series of blood tests to check for specific genetic changes over time
- People in Cohort A: those who completed a type of radiation therapy called PRRT within the last 5 years before joining the trial
- People in Cohort B: those who are scheduled to start PRRT treatment within 4 months of joining the trial
- People in Cohort C: those who have been diagnosed with a blood condition called MDS or AML after having previously received PRRT treatment
Who may not be able to join:
- People who are unwilling to provide blood samples or attend follow-up appointments as required by the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 416-946-4501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identify individuals predisposed to developing MDS/AML to improve patient selection for PRRT where alternative treatment options are available.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.